The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients
Open accessAbstract
BACKGROUND & AIMS Drugs that inhibit gastric acid might increase the risk of hip fracture. However, little long-term exposure data exist and no large studies have been conducted in the United States. METHODS We conducted a case-control study using data from an integrated health services organization. We evaluated 33,752 patients with incident diagnoses of hip/femur fractures (cases), 130,471 matched members without fractures (controls), prescription data for use of proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2RAs) (up to 10 years cumulative duration), and confounders. RESULTS Patients with hip fractures were more likely than controls to have previously received ≥2 years supply of PPIs (odds ratio [OR]=1.30, 95% confidence interval [CI]=1.21–1.39) or H2RAs (OR=1.18, 95% CI=1.08–1.29). The risk was reduced after medication discontinuation (OR=1.30, 95% CI 1.21–1.41 for current PPI users vs. OR=1.09, 95% CI 0.64–1.85 for patients who received their last prescription was 3–5 years ago). Higher dosages (but not increasing cumulative durations) were associated with increased risk (e.g. ≥1.5 pills/day OR=1.41, 95% CI 1.21–1.64; <0.74 pills/day OR=1.12, 95% CI 0.94–1.33). Excess fracture risk for PPI use was only present among persons with at least one other fracture risk factor. CONCLUSION Use of drugs that inhibit gastric acid is associated with an increased risk of hip fracture; however, this association was only found among persons with at least one other risk factor for hip fracture. Acid inhibition might therefore be associated with fracture risk in persons already at risk for osteoporosis, although other confounding cannot be excluded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
Epidemiologic Research: Principles and Quantitative Methods.
Mayer, L. S., Kleinbaum, D. G., Kupper, L. L., & Morgenstern, H. (1984) · Journal of the American Statistical Association · doi:10.2307/2288427 · Cited by 2,905
Incidence and Mortality of Hip Fractures in the United States
Brauer, C. A. (2009) · JAMA · doi:10.1001/jama.2009.1462 · Cited by 1,654
Krieger, N. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,654
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Graham, D. J., Campen, D., Hui, R., Spence, M., Cheetham, C., Levy, G., Shoor, S., & Ray, W. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17864-7 · Cited by 913
Epidemiologic research—1964–1967
Greene, J. C. (1968) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1968.0207 · Cited by 568
Maximum likelihood estimation of the attributable fraction from logistic models.
Greenland, S., & Drescher, K. (1993) · Biometrics · doi:10.2307/2532206 · Cited by 565
Calcium Absorption and Achlorhydria
Recker, R. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130202 · Cited by 502
Use of proton pump inhibitors and risk of osteoporosis-related fractures
Targownik, L. E., Lix, L. M., Metge, C. J., Prior, H. J., Leung, S., & Leslie, W. D. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071330 · Cited by 436
Parker, M., & Johansen, A. (2006) · BMJ · doi:10.1136/bmj.333.7557.27 · Cited by 428
O’Connell, M. B., Madden, D. M., Murray, A. M., Heaney, R. P., & Kerzner, L. J. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.007 · Cited by 405
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0021-7 · Cited by 372
Targownik, L. E., Lix, L. M., Leung, S., & Leslie, W. D. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.014 · Cited by 253
Factors Associated With 5-Year Risk of Hip Fracture in Postmenopausal Women
Robbins, J., Aragaki, A. K., Kooperberg, C., Watts, N., Wactawski-Wende, J., Jackson, R. D., LeBoff, M. S., Lewis, C. E., Chen, Z., Stefanick, M. L., et al. (2007) · JAMA · doi:10.1001/jama.298.20.2389 · Cited by 246
Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans
Mizunashi, K., Furukawa, Y., Katano, K., & Abe, K. (1993) · Calcified Tissue International · doi:10.1007/bf01352010 · Cited by 238
Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults
Yu, E. W., Blackwell, T., Ensrud, K. E., Hillier, T. A., Lane, N. E., Orwoll, E., & Bauer, D. C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9170-1 · Cited by 210
Regional variation in the incidence of hip fracture. US white women aged 65 years and older
Jacobsen, S. J. (1990) · JAMA · doi:10.1001/jama.264.4.500 · Cited by 189
Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
Kaye, J. A., & Jick, H. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.8.951 · Cited by 182
Karsdal, M. A., Henriksen, K., Sørensen, M. G., Gram, J., Schaller, S., Dziegiel, M. H., Heegaard, A., Christophersen, P., Martin, T. J., Christiansen, C., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62269-9 · Cited by 168
Mattsson, J. P., Väänänen, K., Wallmark, B., & Lorentzon, P. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90238-4 · Cited by 167
Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro
Tuukkanen, J., & Väänänen, H. K. (1986) · Calcified Tissue International · doi:10.1007/bf02556841 · Cited by 164
Serfaty-Lacrosnière, C., Wood, R. J., Voytko, D. A., Saltzman, J. R., Pedrosa, M. C., Sepe, T. E., & Russell, R. R. (1995) · Journal of the American College of Nutrition · doi:10.1080/07315724.1995.10718522 · Cited by 144
Benzodiazepines and hip fractures in elderly people: case-control study
Pierfitte, C., Macouillard, G., Thicoïpe, M., Chaslerie, A., Pehourcq, F., Aïssou, M., Martinez, B., Lagnaoui, R., Fourrier, A., Bégaud, B., et al. (2001) · BMJ · doi:10.1136/bmj.322.7288.704 · Cited by 131
Regional Variation in the Incidence of Hip Fracture
Jacobsen, S. J. (1990) · JAMA · doi:10.1001/jama.1990.03450040096038 · Cited by 124
Validation of a β-agonist long-term asthma control scale derived from computerized pharmacy data
Schatz, M. X., Zeiger, R. S., Vollmer, W. M., Mosen, D. M., Apter, A. J., Stibolt, T. B., Leong, A., Johnson, M. S., Mendoza, G., & Cook, E. F. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.053 · Cited by 104
de Vries, F., Cooper, A., Cockle, S. M., van Staa, T. P., & Cooper, C. C. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0891-4 · Cited by 102
The Effect of Proton Pump-Inhibiting Drugs on Mineral Metabolism
Insogna, K. L. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.44 · Cited by 86
Mineral Density and Bone Strength Are Dissociated in Long Bones of Rat Osteopetrotic Mutations
Tuukkanen, J., Koivukangas, A., Jämsä, T. J., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.1905 · Cited by 48
Rümenapf, G., Schwille, P. O., Erben, R. G., Schreiber, M., Bergé, B., Fries, W., Schmiedl, A., Koroma, S., & Hohenberger, W. (1998) · Calcified Tissue International · doi:10.1007/s002239900553 · Cited by 38
Schwille, P. O., Gepp, H., Koch, M., Erben, R. G., Rümenapf, G., Schmiedl, A., & Fries, W. (2001) · Research in Experimental Medicine · doi:10.1007/s004330000048 · Cited by 9
Cited by
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Gerson, L. B., & Vela, M. F. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.444 · Cited by 1,767
Complications of Proton Pump Inhibitor Therapy
Vaezi, M. F., Yang, Y.-X., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.047 · Cited by 482
Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia
Shaheen, N. J., Overholt, B. F., Sampliner, R. E., Wolfsen, H. C., Wang, K. K., Fleischer, D. E., Sharma, V. K., Eisen, G. M., Fennerty, M. B., Hunter, J. G., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.061 · Cited by 451
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
Sheen, E., & Triadafilopoulos, G. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1560-3 · Cited by 307
Proton-pump inhibitors: understanding the complications and risks
Malfertheiner, P., Kandulski, A., & Venerito, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.117 · Cited by 297
Metadata
- Authors
- Corley, D. A., Kubo, A., Zhao, W., & Quesenberry, C.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 139
- Issue
- 1
- Pages
- 93-101
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2138735946
- Cited by
- 271
- References
- 34
- FWCI
- 29.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.